CB2 Insights Launches Health Pulse – A Monthly Medical Report Studying and Assessing Real-World Health Outcomes

NEXT STORY
Alimera Sciences Initiates Landmark NEW DAY Clinical Trial to Evaluate ILUVIEN® as Baseline Therapy for Diabetic Macular Edema
PREV STORY
BioXcel Therapeutics Announces Compassionate Use Program at Massachusetts General Hospital for BXCL501 to Treat COVID-19 Patients Suffering from Delirium and Agitation
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Surya Psychiatric Clinic Brings Revolutionary FDA-Cleared Mental Health Technology for Major Depressive Disorder (MDD) to Patients in Arizona

author_avatar
NASDAQ Market News

Two-Year Update From CytoDyn’s PRO 140 Monotherapy Study in HIV to be Featured in Two Events at CROI 2017

VANCOUVER, Washington, Feb. 14, 2017 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company ...

author_avatar
NASDAQ Market News

CRISPR Therapeutics and Vertex to Host Investor Webcast to Review Data Presented at the 62nd American Society of Hematology Annual (ASH) Meeting and Exposition for Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001™ in Sickle Cell Disease and Beta Thalassemia

author_avatar
NASDAQ Market News